Puma Biotech (PBYI) Tops Q3 EPS by 113c

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of ($1.36), $1.13 better than the analyst estimate of ($2.49). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $3.74 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance